5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Indegene Ltd.

•
indegene.comBSE: 544172NSE: INDGN
Market Cap₹ 13,929 Cr.
Current Price
High / Low₹ 616 / 414
Stock P/E34.7
Book Value₹ 133
Price to Book3.38
Dividend Yield0.39 %
ROCE18.9 %
ROE14.1 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Commercial: 70.1% • Medical: 26.5% • Other: 3.4%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 25.0%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 20.7%
  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 29.4% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.40x)

CONS

  • Recent results are weak - TTM profit is down 14.3% versus prior year
  • Recurring exceptional / one-off items are inflating headline profit
  • Though reporting repeated profits, the company pays out little dividend (13.5%)
  • Expensive relative to growth - PEG of 2.4

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareBusiness ServicesBusiness Support
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.PFOCUS310.60209.2824188.720.00-457.78-514.4312668.151196.882.7423.76
2.SAGILITY45.1521.2821136.200.33216.8145.941963.4827.5913.8222.32
3.HORIZONIND55.65244.0316043.350.00-116.27—2005.46—3.3280.26
4.SYNGENE382.6569.8915446.400.33-9.00-110.38736.00-15.849.4812.34
5.INDGN578.0534.7413929.080.39116.20-0.171063.1039.7318.9216.39
6.IGIL314.2022.2713578.461.59165.7430.98370.7823.2277.0060.35
7.NESCO1102.7518.657769.970.6399.963.97211.809.5519.2348.33
8.LEAPIND144.55102.156367.950.00247.33—2034.13—9.3251.19
9.SPARC196.104.026363.870.00-20.7859.9439.92314.11163.94-85.17
10.SMARTWORKS530.60217.746069.060.0013.15413.27546.2544.0561.1263.33
11.JUSTDIAL665.1015.595656.610.00115.7438.44270.2716.2312.8826.17
12.LATENTVIEW252.5026.765228.850.0047.10-6.84286.8821.5516.6919.76
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
6086366736736766877207567618049421,0031,063
511515524534548561589608606664783840939
Operating Profit97121149139129126132148155141160164124
OPM %15.93%19.05%22.11%20.61%19.05%18.36%18.30%19.52%20.41%17.48%16.93%16.30%11.64%
2812132622213826222019-1029
Interest131212121243344576
Depreciation20201818201920212223404244
Profit before Tax92101132134120124146149152133135105153
Tax %26.05%25.45%25.32%28.99%26.67%26.11%25.02%21.23%23.47%23.29%23.61%24.17%23.90%
Net Profit0000889211011811610210380116
3.093.384.454.273.793.844.594.914.864.264.293.324.84

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
4724755536439661,6652,3062,5902,8393,5103,813
4024475114997361,3781,9102,0842,3052,8923,225
Operating Profit702842144231287396505534619587
OPM %14.87%5.93%7.56%22.34%23.86%17.24%17.17%19.52%18.82%17.63%15.41%
137-4034-2158791075259
Interest10869763149221922
Depreciation191217192633607680126149
Profit before Tax42112675231226363459539525526
Tax %7.58%62.91%45.21%34.66%19.78%28.11%26.69%26.58%24.59%23.60%23.73%
Net Profit3941449186163266337407401401
EPS211.0314.5949.92-40.087.017.4611.9715.1716.9816.68—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.78%13.49%—

COMPOUNDED SALES GROWTH

10 Years:
26%
5 Years:
29%
3 Years:
15%

COMPOUNDED PROFIT GROWTH

10 Years:
27%
5 Years:
22%
3 Years:
15%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
2%

RETURN ON EQUITY

10 Years:
45%
5 Years:
24%
3 Years:
21%
Last Year:
14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 31

₹ 1.12

Rs.2.2500 per share(112.5%)Final Dividend

2025

Jun 13

₹ 1

Rs.2.0000 per share(100%)Final Dividend

2026

Jul 15

₹ 1.12

Rs.2.2500 per share(112.5%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
00000044444848
Minority Interest00089900000
515570-1103207581,0021,3532,5323,044
6641695655813061647287308
Trade Payables4738475550747311893181
147174141-38122322402487476962
Total Liabilities3103083265625591,2842,1372,4753,2364,544
8175104119861386646466781,812
Capital Work in Progress00000000412
1001301206147961,2901,100
0000000648751982
Cash & Bank1893718014051786191375382
210224185249333509773194139257
Total Assets3103083265625591,2842,1372,4753,2364,544

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
46318249222367238508442651
Cash from Investing-77-21-19-18-24-160-893-327-683-512
Cash from Financing57-12-21136-132233333-66288-83
7-92514016370-4301144756

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters0.000.000.000.000.000.000.000.000.00
3.794.825.035.2410.0411.3011.4810.279.92
3.843.173.984.967.206.958.068.298.74
Government0.000.000.000.000.000.000.000.000.00
92.3792.0191.0089.8082.7581.7480.4581.4481.35

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
Amalgamation/Merger

2026-09-10 - Indegene Limited has informed the Exchange about Amalgamation/Merger of Indirect Wholly Owned Subsidiaries of the Company in Germany

2026-09-08
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Indegene Limited has informed the Exchange about Schedule of meet

2026-08-31
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-31 - Indegene Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-19
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-19 - Indegene Limited has informed the Exchange about Schedule of meet

2026-08-19
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-19 - Indegene Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-17
General Updates

2026-08-17 - Indegene Limited has informed the Exchange about the Transcript of the 28th Annual General Meeting held on August 13, 2026

2026-08-17
Change in Director(s)

2026-08-17 - Indegene Limited has informed the Exchange regarding Change in Director(s) of the company.

2026-08-17
Shareholders meeting

2026-08-17 - Indegene Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 13, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-14
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Indegene Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for INDGN

Loading news…

🤖

AI Stock Analyst

Indegene Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login